Clinical Trial

Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation

Recruiting
View on ClinicalTrials.gov →
Summary
Spinal cord stimulation (SCS) has been shown in previous studies to be capable of restoring motor and autonomic function in patients with chronic complete spinal cord injury (SCI). Clinical studies have demonstrated that SCS enables activation of previously paralyzed muscles, leading to functional improvements in patients in the chronic stage of paralysis through the delivery of activity-based interventions. For most previous studies on SCS in SCI, stimulation was invariably applied to lumbrosacral plexus only. In this study, after signing the consent form, the patient will be assigned for standard surgery with additional implant of the spinal cord stimulator. The investigators propose to conduct the SCS with three phases. For the first phase, SCS over lumbrosacral spinal cord will be activated for 3 months with appropriate stimulation of lower limb muscles for walking together with physiotherapy of individual muscle groups for walking. For the second phase, SCS over lumbrosacral spinal cord will be stopped. SCS over the injury site will be activated for 3 months with appropriate stimulation of lower limb muscles. For the third phase, SCS over both lumbrosacral spinal cord and injury site of spinal cord will be activated for another 3 months with appropriate stimulation of lower limb muscles.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-17.
Status change: Not Yet Recruiting → Recruiting 2025-11-27
Trial Details
NCT Number NCT07139496
Lead Sponsor The University of Hong Kong
Conditions Spinal Cord Injuries (SCI)
Enrollment 5 participants
Start Date 2025-09-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-01